Cross Country Healthcare, Inc. (CCRN)
USD 13.61
(0.59%)
USD 13.61
(0.59%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 129.33 Million USD | -55.56% |
| 2022 | 285.14 Million USD | 89.94% |
| 2021 | 152.35 Million USD | 460.27% |
| 2020 | 2.41 Million USD | 29.5% |
| 2019 | -4.83 Million USD | -25.66% |
| 2018 | -761 Thousand USD | -27.97% |
| 2017 | 18.68 Million USD | -1.99% |
| 2016 | 41.32 Million USD | 15.8% |
| 2015 | 35.09 Million USD | 116.44% |
| 2014 | -19.71 Million USD | 125.36% |
| 2013 | -3.01 Million USD | 246.75% |
| 2012 | -15.6 Million USD | -89.67% |
| 2011 | 21.37 Million USD | -9.59% |
| 2010 | 12.19 Million USD | -28.51% |
| 2009 | 30.61 Million USD | -41.09% |
| 2008 | -189.14 Million USD | 7.96% |
| 2007 | 50.37 Million USD | 20.04% |
| 2006 | 35.19 Million USD | 9.21% |
| 2005 | 38.64 Million USD | -12.4% |
| 2004 | 44.11 Million USD | -22.72% |
| 2003 | 56.2 Million USD | -13.81% |
| 2002 | 64.23 Million USD | 17.88% |
| 2001 | 56.18 Million USD | 24.48% |
| 2000 | 43.84 Million USD | 136.03% |
| 1999 | -125.28 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.31 Million USD | -262.35% |
| 2024 Q1 | 12.75 Million USD | -51.22% |
| 2023 Q4 | 18.02 Million USD | -34.68% |
| 2023 Q3 | 27.59 Million USD | -27.16% |
| 2023 FY | - USD | -55.56% |
| 2023 Q2 | 37.88 Million USD | -31.33% |
| 2023 Q1 | 55.17 Million USD | -4.85% |
| 2022 Q2 | 85.48 Million USD | -12.77% |
| 2022 FY | - USD | 89.94% |
| 2022 Q4 | 57.98 Million USD | -8.47% |
| 2022 Q3 | 63.35 Million USD | -25.88% |
| 2022 Q1 | 97.98 Million USD | 20.19% |
| 2021 Q2 | 22.45 Million USD | -10.82% |
| 2021 Q1 | 25.17 Million USD | 173.76% |
| 2021 FY | - USD | 460.27% |
| 2021 Q4 | 81.53 Million USD | 160.3% |
| 2021 Q3 | 31.32 Million USD | 39.52% |
| 2020 Q3 | 7.2 Million USD | -15.04% |
| 2020 Q2 | 8.48 Million USD | 126.09% |
| 2020 FY | - USD | 29.5% |
| 2020 Q4 | 9.19 Million USD | 27.56% |
| 2020 Q1 | 3.75 Million USD | -49.59% |
| 2019 FY | - USD | -25.66% |
| 2019 Q2 | 5.72 Million USD | 148.7% |
| 2019 Q3 | 6.65 Million USD | 16.31% |
| 2019 Q4 | 7.44 Million USD | 11.9% |
| 2019 Q1 | 2.3 Million USD | -57.26% |
| 2018 Q3 | 7.64 Million USD | -10.08% |
| 2018 Q2 | 8.5 Million USD | 3.44% |
| 2018 FY | - USD | -27.97% |
| 2018 Q1 | 8.22 Million USD | -32.0% |
| 2018 Q4 | 5.38 Million USD | -29.61% |
| 2017 Q1 | 6.03 Million USD | -47.17% |
| 2017 Q2 | 9.98 Million USD | 65.38% |
| 2017 FY | - USD | -1.99% |
| 2017 Q3 | 13.19 Million USD | 32.08% |
| 2017 Q4 | 12.08 Million USD | -8.35% |
| 2016 Q4 | 11.43 Million USD | -7.67% |
| 2016 FY | - USD | 15.8% |
| 2016 Q3 | 12.38 Million USD | 21.31% |
| 2016 Q1 | 8.13 Million USD | -24.47% |
| 2016 Q2 | 10.2 Million USD | 25.52% |
| 2015 Q4 | 10.76 Million USD | -12.91% |
| 2015 Q3 | 12.35 Million USD | 66.0% |
| 2015 FY | - USD | 116.44% |
| 2015 Q1 | 5.82 Million USD | -5.0% |
| 2015 Q2 | 7.44 Million USD | 27.75% |
| 2014 Q1 | 935 Thousand USD | -43.44% |
| 2014 FY | - USD | 125.36% |
| 2014 Q4 | 6.13 Million USD | -5.18% |
| 2014 Q3 | 6.47 Million USD | 97.5% |
| 2014 Q2 | 3.27 Million USD | 250.37% |
| 2013 Q2 | 1.22 Million USD | -34.56% |
| 2013 Q3 | 2.71 Million USD | 121.39% |
| 2013 Q4 | 1.65 Million USD | -39.05% |
| 2013 FY | - USD | 246.75% |
| 2013 Q1 | 1.87 Million USD | 105.26% |
| 2012 Q2 | 844 Thousand USD | -64.43% |
| 2012 Q3 | 1.92 Million USD | 128.55% |
| 2012 Q4 | 912 Thousand USD | -52.72% |
| 2012 Q1 | 2.37 Million USD | -53.82% |
| 2012 FY | - USD | -89.67% |
| 2011 Q4 | 5.13 Million USD | -21.37% |
| 2011 FY | - USD | -9.59% |
| 2011 Q2 | 5.28 Million USD | 36.62% |
| 2011 Q1 | 3.86 Million USD | -26.65% |
| 2011 Q3 | 6.53 Million USD | 23.72% |
| 2010 Q4 | 5.27 Million USD | -7.25% |
| 2010 Q1 | 5.53 Million USD | -22.11% |
| 2010 Q2 | 6.54 Million USD | 18.13% |
| 2010 Q3 | 5.68 Million USD | -13.1% |
| 2010 FY | - USD | -28.51% |
| 2009 Q4 | 7.1 Million USD | 4.55% |
| 2009 FY | - USD | -41.09% |
| 2009 Q1 | 10.49 Million USD | -30.08% |
| 2009 Q2 | 7.82 Million USD | -25.44% |
| 2009 Q3 | 6.79 Million USD | -13.07% |
| 2008 Q4 | 15 Million USD | 9.66% |
| 2008 FY | - USD | 7.96% |
| 2008 Q3 | 13.68 Million USD | 1.47% |
| 2008 Q2 | 13.48 Million USD | 7.67% |
| 2008 Q1 | 12.52 Million USD | -15.62% |
| 2007 Q2 | 11.2 Million USD | 9.95% |
| 2007 Q4 | 14.83 Million USD | 2.83% |
| 2007 Q1 | 10.18 Million USD | -19.01% |
| 2007 Q3 | 14.43 Million USD | 28.85% |
| 2007 FY | - USD | 20.04% |
| 2006 FY | - USD | 9.21% |
| 2006 Q4 | 12.57 Million USD | 14.31% |
| 2006 Q1 | 9.34 Million USD | -27.34% |
| 2006 Q2 | 9.27 Million USD | -0.73% |
| 2006 Q3 | 11 Million USD | 18.62% |
| 2005 Q1 | 8.65 Million USD | -18.62% |
| 2005 FY | - USD | -12.4% |
| 2005 Q2 | 4.68 Million USD | -45.84% |
| 2005 Q3 | 11.07 Million USD | 136.38% |
| 2005 Q4 | 12.86 Million USD | 16.08% |
| 2004 FY | - USD | -22.72% |
| 2004 Q2 | 11.17 Million USD | -2.62% |
| 2004 Q3 | 10.86 Million USD | -2.7% |
| 2004 Q4 | 10.63 Million USD | -2.16% |
| 2004 Q1 | 11.47 Million USD | -12.3% |
| 2003 Q2 | 14.6 Million USD | 0.74% |
| 2003 Q3 | 14.89 Million USD | 1.89% |
| 2003 Q4 | 13.07 Million USD | -12.17% |
| 2003 FY | - USD | -13.81% |
| 2003 Q1 | 14.5 Million USD | -17.02% |
| 2002 Q2 | 14.75 Million USD | 3.99% |
| 2002 Q3 | 15.06 Million USD | 3.75% |
| 2002 Q1 | 14.64 Million USD | -8.51% |
| 2002 FY | - USD | 17.88% |
| 2002 Q4 | 17.96 Million USD | 3.52% |
| 2001 FY | - USD | 24.48% |
| 2001 Q2 | 111.35 Million USD | 0.0% |
| 2001 Q1 | 111.35 Million USD | 0.0% |
| 2001 Q3 | 11.32 Million USD | -85.77% |
| 2001 Q4 | 17.1 Million USD | 8.01% |
| 2000 FY | - USD | 136.03% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 31.61% |
| Addus HomeCare Corporation | 106.55 Million USD | -21.375% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -356.82% |
| Amedisys, Inc. | 216.91 Million USD | 40.375% |
| Astrana Health, Inc. | 123.68 Million USD | -4.566% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -191.637% |
| IMAC Holdings, Inc. | -5.94 Million USD | 2274.869% |
| biote Corp. | 9.23 Million USD | -1300.639% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 1341.542% |
| COMPASS Pathways plc | -123.8 Million USD | 204.469% |
| DocGo Inc. | 32.72 Million USD | -295.216% |
| The Ensign Group, Inc. | 353.23 Million USD | 63.386% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -71.961% |
| InnovAge Holding Corp. | 1.15 Million USD | -11107.539% |
| The Joint Corp. | 9.14 Million USD | -1314.778% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 223.263% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 931.487% |
| ModivCare Inc. | -26.75 Million USD | 583.495% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -33554.259% |
| Option Care Health, Inc. | 376.79 Million USD | 65.675% |
| P3 Health Partners Inc. | -81.07 Million USD | 259.533% |
| P3 Health Partners Inc. | -81.07 Million USD | 259.533% |
| The Pennant Group, Inc. | 30.36 Million USD | -325.878% |
| Surgery Partners, Inc. | 446.1 Million USD | 71.008% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 4660.656% |
| Talkspace, Inc. | -22.01 Million USD | 687.539% |
| Talkspace, Inc. | -22.01 Million USD | 687.539% |
| The Oncology Institute, Inc. | -70.45 Million USD | 283.574% |
| The Oncology Institute, Inc. | -70.45 Million USD | 283.574% |